As a monoamine reuptake inhibitor, Tesofensine influences key neurotransmitters such as dopamine, serotonin, and norepinephrine, making it a valuable subject in scientific research
10.1111/1751-2980.12988 J Dig Dis
Ingredients Water, Butylene Glycol, Glycerin, Methylpropanediol, Niacinamide, Propanediol, 1,2-Hexanediol, Betaine, Carbomer, Hydroxyacetophe- none, Tromethamine, Glycereth-25 PCA Isostearate, Sea Water, Diphenyl Dimethicone, Panthenol, Triethylhexanoin, Ethylhexylglycerin, Xanthan Gum, Adenosine, Disodium EDTA, Fragrance, Hydrogenated Lecithin, Polyglyceryl-10 Oleate, Biosaccharide Gum-1, Glutathione, Hyaluronic Acid, Hydrolyzed Hyaluronic Acid, Sodium DNA, Sodium Hyaluronate, Stellaria Media (Chickweed) Extract, Lactobacillus Ferment, Aloe Barbadensis Leaf Extract, Dioscorea Japonica Root Extract, Hibiscus Esculentus Fruit Extract, Malva Sylvestris (Mallow) Extract, Saccharide Isomerate, Alanine, Glutamic Acid, Glycine, Serine, Threonine, Calendula Officinalis Flower Extract, PCA, Hamamelis Virginiana (Witch Hazel) Leaf Extract, Centella Asiatica Extract, Citric Acid, Sodium Citrate, Ascorbic Acid, Helianthus Annuus (Sunflower) Seed Oil, Tranexamic Acid, Caprylic/Capric Triglyceride, Ceramide NP Content 150 ml / 1.07 fl oz For Topical and Cosmetic Use Only
Standard Research Protocols Most research studies, regardless of whether they use "epithalon" or "epitalon," follow similar experimental frameworks: Typical Research Dosages : Low dose studies: 0.1-1 mg per administration Standard protocols: 1-5 mg per research cycle Extended studies: 10-50 mg total over research periods Administration Methods : Subcutaneous injection (most common in research) Intravenous administration (clinical studies) Oral formulations (limited bioavailability studies) For researchers interested in epithalon 50mg formulations, understanding proper reconstitution and handling procedures is essential for maintaining peptide integrity
(August 2013)
